Loading clinical trials...
Loading clinical trials...
The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HRA Pharma
NCT06162611 · Emergency Contraception
NCT03614494 · Emergency Contraception
NCT02078414 · Emergency Contraception, Contraception, and more
NCT03208985 · Emergency Contraception
NCT03395756 · Emergency Contraception, Contraception
Planned Parenthood Federation of America, Inc
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions